Medtech company Shoulder Innovations has commercially launched the InSet 70 Humeral Stem.
The new implant is indicated for anatomic and reverse shoulder arthroplasty procedures, according to a Sept. 22 news release from Shoulder Innovations.
Clinical needs that are addressed by the InSet 70 includes non-inflammatory degenerative joint disease and correction of functional deformity.
The commercial launch of the implant expands the company’s I-Series humeral stem product line, the release said.
